
France Launches Therapeutic Cannabis Trial with Six International Suppliers
France's therapeutic cannabis trial will treat 3,000 patients with products from six international suppliers, marking a pivotal step in validating cannabis-based treatments
- •France's cannabis trial to treat 3,000 patients begins in March
- •Six international companies selected as suppliers; no French producers involved
- •Aurora and Tilray, Canadian firms, secured primary supply roles
by six-entreprises-cannabis-therapeutique-france



















